-2.80%
Today
Loading 1D prices…
Company profile
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Berkeley, CA, United States
Fiscal year end
1231
CIK
1859807
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| AEMDAethlon Medical Inc. Common Stock | $1.1M | $0.00 | — | -$10.61 | -1.92% | Hold |
| GCTKGlucoTrack Inc. Common Stock | $2M | $0.00 | — | $31.22 | -21.05% | Unrated |
| BJDXBluejay Diagnostics Inc. Common Stock | $928.4K | $0.00 | — | -$15.25 | -11.19% | Unrated |
| IVFINVO Fertility Inc. Common Stock | $2.4M | $6.8M | +340.92% | -$214.64 | +0.52% | Buy |
| NXGLNexGel Inc Common Stock | $2.8M | $11.4M | -26.27% | -$0.38 | +0.41% | Hold |